Title: Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy.
Journal: International journal of radiation oncology, biology, physics20120715
Title: Antifungal resistance and new strategies to control fungal infections.
Journal: International journal of microbiology20120101
Title: Targeting the human EGFR family in esophagogastric cancer.
Journal: Nature reviews. Clinical oncology20110405
Title: Changing management and survival in patients with stage IV colorectal cancer.
Journal: Diseases of the colon and rectum20110201
Title: Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.
Journal: Cancer chemotherapy and pharmacology20110101
Title: HER2 Testing in Gastric/Gastroesophageal Junction Adenocarcinomas: Unique Features of a Familiar Test.
Journal: Gastrointestinal cancer research : GCR20110101
Title: Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.
Journal: Cancer20101001
Title: [The role of oral fluoropyrimidines in colorectal cancer treatment--a review].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy20100701
Title: A case with synchronous multiple liver metastases from gastric carcinoma: postoperative long-term disease-free survival.
Journal: Langenbeck's archives of surgery20090701
Title: Commentary 2008: 25 or 50 years later?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology20081020
Title: Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
Journal: The oncologist20080701
Title: [Genetic polymorphisms related to fluoropyrimidine sensitivity and toxicity].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy20080701
Title: Key labeling technologies to tackle sizeable problems in RNA structural biology.
Journal: International journal of molecular sciences20080601
Title: A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).
Journal: British journal of cancer20080226
Title: [Pharmacogenetics in fluoropyrimidine chemotherapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy20080201
Title: Synthesis of 5-fluoropyrimidine nucleotides as sensitive NMR probes of RNA structure.
Journal: Journal of the American Chemical Society20071205
Title: Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype.
Journal: Cancer letters20061028
Title: [Multicenter phase II study of modified FOLFIRI regimen in the advanced colorectal cancer patient refractory to fluoropyrimidine and oxaliplatin].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]20061001
Title: Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosine.
Journal: Human gene therapy20060501
Title: Analysis of pyrimidine catabolism in Drosophila melanogaster using epistatic interactions with mutations of pyrimidine biosynthesis and beta-alanine metabolism.
Journal: Genetics20060301
Title: [5 -fluoropyrimidines for treatment of biliary tract cancers].
Journal: Nihon rinsho. Japanese journal of clinical medicine20060101
Title: Interest of fluorine-19 nuclear magnetic resonance spectroscopy in the detection, identification and quantification of metabolites of anticancer and antifungal fluoropyrimidine drugs in human biofluids.
Journal: Chemotherapy20060101
Title: Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics.
Journal: Pharmacogenomics20051201
Title: A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.
Journal: Japanese journal of clinical oncology20051101
Title: Development of a stereological method to measure levels of fluoropyrimidine metabolizing enzymes in tumor sections using laser scanning cytometry.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20050401
Title: DNA mismatch repair-dependent response to fluoropyrimidine-generated damage.
Journal: The Journal of biological chemistry20050218
Title: Pathways of pyrimidine salvage in Streptomyces.
Journal: Current microbiology20050101
Title: Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
Journal: Anticancer research20050101
Title: Combination of oral fluoropyrimidine and docetaxel: reappraisal of synergistic effect against gastric carcinoma xenografts.
Journal: In vivo (Athens, Greece)20050101
Title: Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer.
Journal: Cancer chemotherapy and pharmacology20041201
Title: [Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy20041001
Title: Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20040801
Title: Potential for predicting toxicity and response of fluoropyrimidines in patients.
Journal: Current drug targets20040501
Title: Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: identification of responders incorporating the age factor.
Journal: Oncology reports20040301
Title: The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors.
Journal: Anti-cancer drugs20040201
Title: [The clinical importance of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the 5-fluoropyrimidine-based therapy of metastatic colorectal tumours].
Journal: Magyar onkologia20040101
Title: A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage.
Journal: Oncogene20031020
Title: ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20031015
Title: Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time?
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20030401
Title: [The antitumor activity of DPD inhibitory-fluoropyrimidine (DIF) and non-DIF alone or in combination with paclitaxel against orthotopically implanted human breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy20020501
Title: Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Association between host or tumor factors and survival.
Journal: International journal of oncology20020201
Title: Tumor dihydropyrimidine dehydrogenase activity in advanced cervical carcinoma.
Journal: Oncology reports20020101
